De Pas TM - Search Results

1

Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.

Valenza C, De Pas TM, Gaeta A, Castellano G, Santoro C, Corona A, Chiappini G, Vivanet G, Trapani D, Coppola S, Conforti F, Mattar D, Gandini S, Veronesi P, Pennacchioli E, Curigliano G. Valenza C, et al. Among authors: de pas tm. Eur J Cancer. 2024 Jan;196:113423. doi: 10.1016/j.ejca.2023.113423. Epub 2023 Nov 10. Eur J Cancer. 2024. PMID: 37977104

2

Ifosfamide in the elderly: clinical considerations for a better drug management.

De Pas T, Curigliano G, Catania C, Comandone A, de Braud F. De Pas T, et al. Crit Rev Oncol Hematol. 2000 Feb;33(2):129-35. doi: 10.1016/s1040-8428(99)00060-8. Crit Rev Oncol Hematol. 2000. PMID: 10737374 Review.

3

Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703.

De Pas TM, Mandalà M, Curigliano G, Peccatori F. De Pas TM, et al. Obstet Gynecol. 2000 Jun;95(6 Pt 2):1030. Obstet Gynecol. 2000. PMID: 10808018 No abstract available.

4

GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.

Curigliano G, Ferretti G, Mandalà M, De Pas T, Calabrò MG, Solli P, Noberasc C, de Braud F. Curigliano G, et al. Anticancer Res. 2001 Sep-Oct;21(5):3461-9. Anticancer Res. 2001. PMID: 11848510

5

Imatinib administration in two patients with liver metastases from GIST and severe jaundice.

De Pas T, Danesi R, Catania C, Curigliano G, De Braud F; Italia Sarcoma Group. De Pas T, et al. Br J Cancer. 2003 Oct 20;89(8):1403-4. doi: 10.1038/sj.bjc.6601282. Br J Cancer. 2003. PMID: 14562006 Free PMC article.

6

Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study.

De Pas T, Curigliano G, Veronesi G, Catalano G, Catania C, Jereczek-Fossa B, Orecchia R, Spaggiari L, de Braud F. De Pas T, et al. Bull Cancer. 2004 Sep 1;91(9):E273-7. Print 2004 Sep. Bull Cancer. 2004. PMID: 15582897 Free article. Clinical Trial.

7

Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare.

De Pas T, Pelosi G, de Braud F, Veronesi G, Curigliano G, Leon ME, Danesi R, Noberasco C, d'Aiuto M, Catalano G, Viale G, Spaggiari L. De Pas T, et al. J Clin Oncol. 2004 Dec 15;22(24):4966-70. doi: 10.1200/JCO.2004.01.195. J Clin Oncol. 2004. PMID: 15611511 Free article.

8

Video-assisted management of malignant pleural effusion in breast carcinoma.

Gasparri R, Leo F, Veronesi G, De Pas T, Colleoni M, Maisonneuve P, Pelosi G, Galimberti V, Spaggiari L. Gasparri R, et al. Cancer. 2006 Jan 15;106(2):271-6. doi: 10.1002/cncr.21623. Cancer. 2006. PMID: 16342163 Free article.

9

A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients.

De Pas T, Putzu C, Curigliano G, Noberasco C, Boselli S, Catania C, Orlando L, Milani A, Spaggiari L, de Braud F. De Pas T, et al. Lung Cancer. 2006 Dec;54(3):359-64. doi: 10.1016/j.lungcan.2006.08.016. Epub 2006 Oct 6. Lung Cancer. 2006. PMID: 17028052

10

Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib.

Curigliano G, Pelosi G, De Pas T, Renne G, De Cobelli O, Manzotti M, Spitaleri G, de Braud F. Curigliano G, et al. Prostate. 2007 May 1;67(6):603-4. doi: 10.1002/pros.20530. Prostate. 2007. PMID: 17290443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters